ZNF273 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.617150857669E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.11639999467172E-08 |
Normal-vs-Stage2 |
4.643900E-03 |
Normal-vs-Stage3 |
3.461500E-03 |
Normal-vs-Stage4 |
2.286300E-02 |
Stage1-vs-Stage2 |
5.143000E-01 |
Stage1-vs-Stage3 |
3.261800E-01 |
Stage1-vs-Stage4 |
6.215400E-01 |
Stage2-vs-Stage3 |
2.595000E-01 |
Stage2-vs-Stage4 |
9.991600E-01 |
Stage3-vs-Stage4 |
2.665000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.26969545988231E-11 |
Normal-vs-AfricanAmerican |
3.57859999999821E-05 |
Normal-vs-Asian |
7.150000E-02 |
Caucasian-vs-AfricanAmerican |
9.784800E-01 |
Caucasian-vs-Asian |
8.367200E-01 |
AfricanAmerican-vs-Asian |
8.479200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.1967982988258E-11 |
Normal-vs-Female |
1.53719999951285E-07 |
Male-vs-Female |
9.716400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
5.90349999999296E-05 |
Normal-vs-Extreme_Weight |
2.22350000000926E-06 |
Normal-vs-Obese |
2.18939999996337E-06 |
Normal-vs-Extreme_Obese |
1.008160E-01 |
Normal_Weight-vs-Extreme_Weight |
1.664830E-01 |
Normal_Weight-vs-Obese |
5.219200E-01 |
Normal_Weight-vs-Extreme_Obese |
9.649600E-02 |
Extreme_Weight-vs-Obese |
3.426000E-01 |
Extreme_Weight-vs-Extreme_Obese |
5.152600E-01 |
Obese-vs-Extreme_Obese |
3.131800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.923500E-03 |
Normal-vs-Age(41-60Yrs) |
1.19599996573072E-09 |
Normal-vs-Age(61-80Yrs) |
4.7236003997142E-10 |
Normal-vs-Age(81-100Yrs) |
3.479400E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.376600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.793640E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.414030E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.127800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.341300E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.535900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.67388325422735E-12 |
Normal-VS-Type2 PRCC |
1.517910E-02 |
Normal-VS-KIRP CIMP |
2.895800E-02 |
Normal-VS-Unclassified PRCC |
2.238800E-04 |
Type1 PRCC-VS-Type2 PRCC |
1.30630000039211E-07 |
Type1 PRCC-VS-KIRP CIMP |
9.216800E-03 |
Type1 PRCC-VS-Unclassified PRCC |
2.455600E-02 |
Type2 PRCC-VS-KIRP CIMP |
7.379800E-01 |
Type2 PRCC-VS-Unclassified PRCC |
4.374400E-02 |
KIRP CIMP-VS-Unclassified PRCC |
3.733200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.555500E-04 |
Normal-vs-N1 |
4.978200E-04 |
Normal-vs-N2 |
2.654200E-01 |
N0-vs-N1 |
3.854000E-01 |
N0-vs-N2 |
8.816400E-01 |
N1-vs-N2 |
5.728600E-01 |
|
|